183 related articles for article (PubMed ID: 33043365)
1. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
[TBL] [Abstract][Full Text] [Related]
2. Paradigmatic De Novo
Santos-Gómez A; Miguez-Cabello F; Juliá-Palacios N; García-Navas D; Soto-Insuga V; García-Peñas JJ; Fuentes P; Ibáñez-Micó S; Cuesta L; Cancho R; Andreo-Lillo P; Gutiérrez-Aguilar G; Alonso-Luengo O; Málaga I; Hedrera-Fernández A; García-Cazorla À; Soto D; Olivella M; Altafaj X
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884460
[TBL] [Abstract][Full Text] [Related]
3. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
[TBL] [Abstract][Full Text] [Related]
4. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
5. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
Tang W; Liu D; Traynelis SF; Yuan H
Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of
Myers SJ; Yuan H; Kang JQ; Tan FCK; Traynelis SF; Low CM
F1000Res; 2019; 8():. PubMed ID: 31807283
[TBL] [Abstract][Full Text] [Related]
7. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.
Korinek M; Serra MC; Abdel Rahman F; Dobrovolski M; Kuchtiak V; Abramova V; Fili K; Tomovic E; Hrcka Krausova B; Krusek J; Cerny J; Vyklicky L; Balik A
Physiol Res; 2024 May; ():. PubMed ID: 38836461
[TBL] [Abstract][Full Text] [Related]
8. De novo GRIN2A variants associated with epilepsy and autism and literature review.
Mangano GD; Riva A; Fontana A; Salpietro V; Mangano GR; Nobile G; Orsini A; Iacomino M; Battini R; Astrea G; Striano P; Nardello R
Epilepsy Behav; 2022 Apr; 129():108604. PubMed ID: 35217385
[TBL] [Abstract][Full Text] [Related]
9. GRIN database: A unified and manually curated repertoire of GRIN variants.
García-Recio A; Santos-Gómez A; Soto D; Julia-Palacios N; García-Cazorla À; Altafaj X; Olivella M
Hum Mutat; 2021 Jan; 42(1):8-18. PubMed ID: 33252190
[TBL] [Abstract][Full Text] [Related]
10. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
[TBL] [Abstract][Full Text] [Related]
11. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
[TBL] [Abstract][Full Text] [Related]
12. Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk.
Demontis D; Nyegaard M; Buttenschøn HN; Hedemand A; Pedersen CB; Grove J; Flint TJ; Nordentoft M; Werge T; Hougaard DM; Sørensen KM; Yolken RH; Mors O; Børglum AD; Mortensen PB
Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(8):913-22. PubMed ID: 21919190
[TBL] [Abstract][Full Text] [Related]
13. De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.
Xu Y; Song R; Perszyk RE; Chen W; Kim S; Park KL; Allen JP; Nocilla KA; Zhang J; XiangWei W; Tankovic A; McDaniels ED; Sheikh R; Mizu RK; Karamchandani MM; Hu C; Kusumoto H; Pecha J; Cappuccio G; Gaitanis J; Sullivan J; Shashi V; Petrovski S; Jauss RT; Lee HK; Bozarth X; Lynch DR; Helbig I; Pierson TM; Boerkoel CF; Myers SJ; Lemke JR; Benke TA; Yuan H; Traynelis SF
Cell Mol Life Sci; 2024 Mar; 81(1):153. PubMed ID: 38538865
[TBL] [Abstract][Full Text] [Related]
14. Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.
Yu Y; Lin Y; Takasaki Y; Wang C; Kimura H; Xing J; Ishizuka K; Toyama M; Kushima I; Mori D; Arioka Y; Uno Y; Shiino T; Nakamura Y; Okada T; Morikawa M; Ikeda M; Iwata N; Okahisa Y; Takaki M; Sakamoto S; Someya T; Egawa J; Usami M; Kodaira M; Yoshimi A; Oya-Ito T; Aleksic B; Ohno K; Ozaki N
Transl Psychiatry; 2018 Jan; 8(1):12. PubMed ID: 29317596
[TBL] [Abstract][Full Text] [Related]
15. Human GRIN2B variants in neurodevelopmental disorders.
Hu C; Chen W; Myers SJ; Yuan H; Traynelis SF
J Pharmacol Sci; 2016 Oct; 132(2):115-121. PubMed ID: 27818011
[TBL] [Abstract][Full Text] [Related]
16. [Neurodevelopmental disorders associated with variants of GRIN gene family].
Jiang X; Dong X; Zhou W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jul; 39(7):783-787. PubMed ID: 35810443
[TBL] [Abstract][Full Text] [Related]
17. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
18. Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants.
Kellner S; Berlin S
Cell Mol Life Sci; 2024 May; 81(1):235. PubMed ID: 38795169
[TBL] [Abstract][Full Text] [Related]
19. Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors.
Song R; Zhang J; Perszyk RE; Camp CR; Tang W; Kannan V; Li J; Xu Y; Chen J; Li Y; Liang SH; Traynelis SF; Yuan H
J Neurochem; 2023 Aug; ():. PubMed ID: 37649269
[TBL] [Abstract][Full Text] [Related]
20. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
